CST5 and systemic mastocytosis: In a previous proteomics study, performed using a top-down platform, we highlighted the presence in saliva of peripheral and non-invasive candidate biomarkers of mastocytosis, some of them able to distinguish subtypes of SM with and without cutaneous symptoms (SM+C and SM−C), such as the R26 variant of cystatin D [13].